Literature DB >> 36173452

High fat diet-induced hyperlipidemia and tissue steatosis in rabbits through modulating ileal microbiota.

Zhiguo Guo1, Qasim Ali1, Muhammad Abaidullah1, Zimin Gao1, Xinying Diao1, Boshuai Liu1, Zhichang Wang1,2,3, Xiaoyan Zhu1,2,3, Yalei Cui1,2,3, Defeng Li1,2,3, Yinghua Shi4,5,6.   

Abstract

High-fat diet (HFD) and overnutrition are important starting factors that may alter intestinal microbiota, lipid metabolism, and systemic inflammation. However, there were few studies on how intestinal microbiota contributes to tissue steatosis and hyperlipidemia. Here, we investigated the effect of lipid metabolism disorder-induced inflammation via toll-like receptor 2 (TLR-2), toll-like receptor 4 (TLR-4), and nuclear factor-κB (NF-κB) pathways at the intestinal level in response to HFD. Twenty 80-day-old male New Zealand White rabbits were randomly divided into the normal diet group (NDG) and the high-fat diet group (HDG) for 80 days. Growth performance, blood biochemical parameters, lipid metabolism, inflammation, degree of tissue steatosis, and intestinal microbial composition were measured. HFD increased the relative abundance of Christensenellaceae_R_7_group, Marvinbryantia, Akkermansia etc., with a reduced relative abundance of Enterorhabdus and Lactobacillus. Moreover, HFD caused steatosis in the liver and abdominal fat and abnormal expression of some genes related to lipid metabolism and tight junction proteins. The TLR-2, TLR-4, NF-κB, TNF-α, and IL-6 were confirmed by overexpression with downregulation of IL-10. Serum biochemical indices (TG, TCHO, LDL-C, and HDL-C) were also increased, indicating evidence for the development of the hyperlipidemia model. Correlation analysis showed that this microbial dysbiosis was correlated with lipid metabolism and inflammation, which were associated with the intestinal tract's barrier function and hyperlipidemia. These results provide an insight into the relationship between HFD, the intestinal microbiota, intestinal barrier, tissue inflammation, lipid metabolism, and hyperlipidemia. KEY POINTS: • High-fat diet leads to ileal microbiota disorders • Ileal microbiota mediates local and systemic lipid metabolism disorders and inflammation • There is a specific link between ileal microbiota, histopathology, and hyperlipidemia.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  High-fat diet; Hyperlipidemia; Lipid metabolism; Microbiota; New Zealand rabbit; Steatosis

Year:  2022        PMID: 36173452     DOI: 10.1007/s00253-022-12203-7

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   5.560


  82 in total

1.  Formation of a functional thymus initiated by a postnatal epithelial progenitor cell.

Authors:  Conrad C Bleul; Tatiana Corbeaux; Alexander Reuter; Paul Fisch; Jürgen Schulte Mönting; Thomas Boehm
Journal:  Nature       Date:  2006-06-22       Impact factor: 49.962

2.  Evaluation of rat and rabbit sera lipoproteins in experimentally induced hyperlipidemia by analytical ultracentrifugation.

Authors:  Z Bozóky; L Balogh; D Máthé; L Fülöp; Gy A Jánoki
Journal:  Eur Biophys J       Date:  2005-11-24       Impact factor: 1.733

Review 3.  Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus.

Authors:  Guido T Bommer; Ormond A MacDougald
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

4.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

5.  Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.

Authors:  Patrice D Cani; Rodrigo Bibiloni; Claude Knauf; Aurélie Waget; Audrey M Neyrinck; Nathalie M Delzenne; Rémy Burcelin
Journal:  Diabetes       Date:  2008-02-27       Impact factor: 9.461

Review 6.  Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.

Authors:  Patrice D Cani; Melania Osto; Lucie Geurts; Amandine Everard
Journal:  Gut Microbes       Date:  2012-05-14

Review 7.  Obesity: global epidemiology and pathogenesis.

Authors:  Matthias Blüher
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

8.  The flavonoid-rich Quzhou Fructus Aurantii extract modulates gut microbiota and prevents obesity in high-fat diet-fed mice.

Authors:  Yong-Feng Bai; Si-Wei Wang; Xiao-Xiao Wang; Yuan-Yuan Weng; Xue-Yu Fan; Hao Sheng; Xin-Tian Zhu; Li-Jun Lou; Feng Zhang
Journal:  Nutr Diabetes       Date:  2019-10-23       Impact factor: 5.097

9.  Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing.

Authors:  Nicholas A Bokulich; Sathish Subramanian; Jeremiah J Faith; Dirk Gevers; Jeffrey I Gordon; Rob Knight; David A Mills; J Gregory Caporaso
Journal:  Nat Methods       Date:  2012-12-02       Impact factor: 28.547

10.  Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling.

Authors:  Robert Caesar; Valentina Tremaroli; Petia Kovatcheva-Datchary; Patrice D Cani; Fredrik Bäckhed
Journal:  Cell Metab       Date:  2015-08-27       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.